Diabetes

Quebec health institute updates its screening checklist to help front-line clinicians assess requests for health check-ups and reduce the number of unnecessary consultations.

InsuJet, the first needleless device for insulin delivery, is now available in Canada. Can you tell which statement about this device is false?

Case series describes the rare development of nonarteritic anterior ischemic optic neuropathy (NAION) in new users of semaglutide or tirzepatide.

Study suggests risk of death is increased nearly 200%; lower with other diabetes treatments.

Study examines the comparative cardiovascular efficacy and safety of sodium-glucose cotransporter 2 (SGLT2) inhibitors in patients with type 2 diabetes.

Novo Nordisk Canada has also warned that compounded semaglutide may expose patients to health risks.

Advise patients to use sugar substitutes in moderation, emphasizing that they are a tool to complement, not replace, a healthy diet.

In this opinion piece, a Quebec family physician and blogger shares his amazement at the wonders of pharmaceutical statistical analysis and interpretation.